A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.

MLA

Tang, P., et al. “A Phase II Study of Carboplatin and Chronic High-Dose Tamoxifen in Patients with Recurrent Malignant Glioma.” Journal of Neuro-Oncology, vol. 78, no. 3, July 2006, pp. 311–16. EBSCOhost, https://doi.org/10.1007/s11060-005-9104-y.

APA

Tang, P., Roldan, G., Brasher, P. M. A., Fulton, D., Roa, W., Murtha, A., Cairncross, J. G., & Forsyth, P. A. (2006). A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma. Journal of Neuro-Oncology, 78(3), 311–316. https://doi.org/10.1007/s11060-005-9104-y

Chicago

Tang, P, G Roldan, P M A Brasher, D Fulton, W Roa, A Murtha, J G Cairncross, and P A Forsyth. 2006. “A Phase II Study of Carboplatin and Chronic High-Dose Tamoxifen in Patients with Recurrent Malignant Glioma.” Journal of Neuro-Oncology 78 (3): 311–16. doi:10.1007/s11060-005-9104-y.